I give up i have one day - just learn this Flashcards
What is Biosecurity?
- Movement & management of animals
- Movement & management of people
- Management of vectors, fomites, etc.
- Management of the environment
Routine biosecurity
everyday control of disease spread
Emergency biosecurity
in the face of a specific threat
What are the organisations that make up the International initiatives: the ”Quadripartite”
FAO, OIE, WHO and UNEP
Biosafety and Biosecurity
Biosafety protects people from nasty germs – biosecurity protects germs from nasty people
Dual Use Research of Concern (DURC)
Legitimate scientific purpose, but possible misuse.
Re-emergence of eradicated threats e.g. polio
Misuse e.g. influenza virus
Clinical Biosecurity
Usually referred to as “Infection Control”
Biohazard
Biological substance that poses a threat – human health,
animal health, agricultural production, trade, etc.
* Typically derived from a biological entity, not just a
hazard to a biological entity
Main types of significance:
* Infectious, including genetic
* Pests
* Chemical
Biosafety
- The safe handling and containment of biohazards
- Protection of people from biological hazards
Biocontainment
- Physical and operational mechanisms to prevent release of or exposure to biohazards
- Mainly refers to labs, mainly microbiological
Intentional Misuse
Bioweapons
Biowarfare
Bioterrorism
Biodefense
Isolation levels
– Individual level: suspect cases until diagnosis established
– Herd level: New animals kept separate before mixing with rest of herd
– National level: Animals coming from countries where disease are endemic (e.g. rabies)
Legacy of Rinderpest
- Establishment of 1st veterinary school: Lyon, 1762
- Creation of the World Organization for Animal Health (WOAH, ex-OIE), 1924
- 2nd disease eradicated globally
- Basis of mass animal quarantine and vaccination campaigns
Approaches: Costs & Benefits
- prevention (save most cost)
- eradication
- containment
- asset-based protection
Drivers for Biosecurity Adaptation
o Increasing use of ‘clean & green’ marketing
o Accelerating globalisation & global trade & travel
o Technical improvements in surveillance & diagnosis
o Increasingly intensive agriculture
o Habitat destruction, climate change, etc.
o EIDs & agro/bioterrorism
Pre-border, border, post-border
pre-border:
* Engage with international trade regulations
* diagnosis, RA surveillance, response)
* Relationships
* Awareness campaigns
border:
- Classical “quarantine”
- Transport & import controls
- Inspection and seizure/treatment (some pre-border)
- Import RA & certification
- Surveillance (e.g. NAQS)
post-border:
- Early detection & response
- Surveillance (e.g. abattoir)
- Proof of freedom programs
- Reporting (State, National, International)
- Risk factor analysis
Typical Vaccine Components
Antigen
- Whole pathogen/component of pathogen
Adjuvant
- Create danger signals
Route of vaccination
- Intramuscular (IM), Intranasal, Oral
Whole “Cell” Vaccine
- Whole bacterium or virus
– Whole bacterium plus toxin
– Inactivated/split
+Adjuvant
Advantages
– No risk of disease
– Not affected by prior exposure
– Multivalent
– Cost effective
Disadvantages
– Multiple doses (3 to 4 weeks)
– Antibody response
Toxoid Vaccine
- Bacterial toxin
- Inactivated
+Adjuvant
Advantages
– No risk of disease
– Not affected by prior exposure
– Multivalent
– Cost effective
Disadvantages
– Multiple doses (3 to 4 weeks)
– Antibody responses
Subunit Vaccine
- A component of the pathogen
- Identification
- Purified, expressed, synthesised
+adjuvant
Advantages
– No risk of disease
– Not affect prior exposure
– Multivalent
Disadvantages
– Multiple doses (3 to 4 weeks)
– Antibody responses
– Costly to produce
Modified Live Vaccine
Antigen”
– Complete pathogen
– Serial passage
– Natural variant
NO ADJUVANT
Advantages
– Mimics infection without disease
– Balanced immune response
– Single-dose (mostly)
Disadvantages
– Reversion to virulence
– Cold chain requirements
– Prior exposure
– Immunocompromised animals
Genetically Modified Vaccine
“Complete” pathogen
NO ADJUVANT
Advantages
– Mimics infection without disease
– Balanced immune response
– Single-dose
– Engineer safety controls
– Multivalent
Disadvantages
– Reversion to virulence
– Cold chain requirements
– Prior exposure
– Immunocompromised animals
immune response
mRNA Vaccine
- Genetic code
- Produced by host cells
NO ADJUVANT
Advantages
– Antigen integrity
– Not affected by prior exposure
– Scalable
– Flexible
Disadvantages
– New
– Multidose
– Cold chain requirements
– Innate immunity
Immune Responses
Innate immune response
– Rapid with a short duration
– Not pathogen specific
Adaptive immune response - antibody
– Slow to develop with long duration
– Matures to generate specific antibodies to antigens
– Extracellular impact on pathogen
– Easy to measure
Adaptive immune response – cell mediated
– Slow to develop with long duration
– Intracellular impact on pathogen
– Difficult to measure
Vaccination
* Ideally a balance of all of the above
* Reality, many vaccines generate strong antibody responses